Due to the increased risk of ASCVD in patients with HIV, aggressive treatment with lifestyle modifications and lipid-lowering therapy are generally recommended.
The nearly five-year study offers no explanation for symptoms including headaches, balance problems and difficulties with thinking and sleep that were first reported in Cuba in 2016 and later by hundreds of American personnel.